vs

Side-by-side financial comparison of HEARTLAND EXPRESS INC (HTLD) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $179.4M, roughly 1.3× HEARTLAND EXPRESS INC). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs -10.8%, a 30.2% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs -26.1%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $-44.2M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -18.5%).

Heartland Express is an American trucking company headquartered in North Liberty, Iowa. The company offers truckload shipping services across the United States.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

HTLD vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.3× larger
ORGO
$225.6M
$179.4M
HTLD
Growing faster (revenue YoY)
ORGO
ORGO
+104.2% gap
ORGO
78.1%
-26.1%
HTLD
Higher net margin
ORGO
ORGO
30.2% more per $
ORGO
19.4%
-10.8%
HTLD
More free cash flow
ORGO
ORGO
$79.0M more FCF
ORGO
$34.8M
$-44.2M
HTLD
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-18.5%
HTLD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HTLD
HTLD
ORGO
ORGO
Revenue
$179.4M
$225.6M
Net Profit
$-19.4M
$43.7M
Gross Margin
Operating Margin
-12.7%
28.1%
Net Margin
-10.8%
19.4%
Revenue YoY
-26.1%
78.1%
Net Profit YoY
-949.2%
469.5%
EPS (diluted)
$-0.24
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTLD
HTLD
ORGO
ORGO
Q4 25
$179.4M
$225.6M
Q3 25
$196.5M
$150.9M
Q2 25
$210.4M
$101.0M
Q1 25
$219.4M
$86.7M
Q4 24
$242.6M
$126.7M
Q3 24
$259.9M
$115.2M
Q2 24
$274.8M
$130.2M
Q1 24
$270.3M
$110.0M
Net Profit
HTLD
HTLD
ORGO
ORGO
Q4 25
$-19.4M
$43.7M
Q3 25
$-8.3M
$21.6M
Q2 25
$-10.9M
$-9.4M
Q1 25
$-13.9M
$-18.8M
Q4 24
$-1.9M
$7.7M
Q3 24
$-9.3M
$12.3M
Q2 24
$-3.5M
$-17.0M
Q1 24
$-15.1M
$-2.1M
Gross Margin
HTLD
HTLD
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
HTLD
HTLD
ORGO
ORGO
Q4 25
-12.7%
28.1%
Q3 25
-3.7%
13.7%
Q2 25
-5.9%
-12.5%
Q1 25
-6.8%
-30.9%
Q4 24
0.4%
8.1%
Q3 24
-2.7%
5.4%
Q2 24
0.1%
-10.7%
Q1 24
-5.3%
-3.5%
Net Margin
HTLD
HTLD
ORGO
ORGO
Q4 25
-10.8%
19.4%
Q3 25
-4.2%
14.3%
Q2 25
-5.2%
-9.3%
Q1 25
-6.3%
-21.7%
Q4 24
-0.8%
6.1%
Q3 24
-3.6%
10.7%
Q2 24
-1.3%
-13.1%
Q1 24
-5.6%
-1.9%
EPS (diluted)
HTLD
HTLD
ORGO
ORGO
Q4 25
$-0.24
$0.31
Q3 25
$-0.11
$0.11
Q2 25
$-0.14
$-0.10
Q1 25
$-0.18
$-0.17
Q4 24
$-0.03
$0.05
Q3 24
$-0.12
$0.09
Q2 24
$-0.04
$-0.13
Q1 24
$-0.19
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTLD
HTLD
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$18.5M
$93.7M
Total DebtLower is stronger
$154.1M
Stockholders' EquityBook value
$755.3M
$300.1M
Total Assets
$1.2B
$598.7M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTLD
HTLD
ORGO
ORGO
Q4 25
$18.5M
$93.7M
Q3 25
$32.7M
$63.7M
Q2 25
$22.9M
$73.1M
Q1 25
$23.9M
$110.0M
Q4 24
$12.8M
$135.6M
Q3 24
$30.7M
$94.3M
Q2 24
$23.9M
$89.9M
Q1 24
$23.8M
$88.6M
Total Debt
HTLD
HTLD
ORGO
ORGO
Q4 25
$154.1M
Q3 25
Q2 25
Q1 25
Q4 24
$187.9M
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
HTLD
HTLD
ORGO
ORGO
Q4 25
$755.3M
$300.1M
Q3 25
$775.6M
$255.1M
Q2 25
$786.7M
$233.2M
Q1 25
$807.7M
$242.9M
Q4 24
$822.6M
$262.9M
Q3 24
$825.7M
$278.5M
Q2 24
$836.8M
$263.5M
Q1 24
$848.8M
$278.0M
Total Assets
HTLD
HTLD
ORGO
ORGO
Q4 25
$1.2B
$598.7M
Q3 25
$1.3B
$509.8M
Q2 25
$1.3B
$461.1M
Q1 25
$1.3B
$467.4M
Q4 24
$1.3B
$497.9M
Q3 24
$1.4B
$446.3M
Q2 24
$1.4B
$443.2M
Q1 24
$1.5B
$458.5M
Debt / Equity
HTLD
HTLD
ORGO
ORGO
Q4 25
0.20×
Q3 25
Q2 25
Q1 25
Q4 24
0.23×
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTLD
HTLD
ORGO
ORGO
Operating Cash FlowLast quarter
$14.9M
$39.4M
Free Cash FlowOCF − Capex
$-44.2M
$34.8M
FCF MarginFCF / Revenue
-24.6%
15.4%
Capex IntensityCapex / Revenue
33.0%
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-66.9M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTLD
HTLD
ORGO
ORGO
Q4 25
$14.9M
$39.4M
Q3 25
$27.5M
$3.1M
Q2 25
$21.0M
$-32.9M
Q1 25
$25.8M
$-19.9M
Q4 24
$37.8M
$10.9M
Q3 24
$35.6M
$8.7M
Q2 24
$40.0M
$4.7M
Q1 24
$31.0M
$-10.2M
Free Cash Flow
HTLD
HTLD
ORGO
ORGO
Q4 25
$-44.2M
$34.8M
Q3 25
$-12.2M
$844.0K
Q2 25
$-12.8M
$-36.5M
Q1 25
$2.3M
$-23.6M
Q4 24
$-45.5M
$7.6M
Q3 24
$24.6M
$6.1M
Q2 24
$29.4M
$2.9M
Q1 24
$26.3M
$-12.4M
FCF Margin
HTLD
HTLD
ORGO
ORGO
Q4 25
-24.6%
15.4%
Q3 25
-6.2%
0.6%
Q2 25
-6.1%
-36.1%
Q1 25
1.0%
-27.2%
Q4 24
-18.8%
6.0%
Q3 24
9.5%
5.3%
Q2 24
10.7%
2.2%
Q1 24
9.7%
-11.3%
Capex Intensity
HTLD
HTLD
ORGO
ORGO
Q4 25
33.0%
2.1%
Q3 25
20.2%
1.5%
Q2 25
16.1%
3.6%
Q1 25
10.7%
4.2%
Q4 24
34.3%
2.7%
Q3 24
4.2%
2.2%
Q2 24
3.8%
1.4%
Q1 24
1.7%
2.0%
Cash Conversion
HTLD
HTLD
ORGO
ORGO
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons